Comparison of Prognosis and Health‐Related Quality of Life Between Robot‐Assisted Radical Prostatectomy Versus High‐Dose‐Rate Brachytherapy Combined With External Beam Radiation Therapy and Hormone Therapy for High‐Risk Prostate Cancer

Documenti analoghi

• TMB‐High, MSI‐High Castration‐Resistant Prostate Cancer Treated With Pembrolizumab
  di: Satoshi Muraoka, et al.
  Pubblicazione: (2025)
• Hormone Therapy With Salvage Radiotherapy After Radical Prostatectomy: A Systematic Review and Meta‐Analysis
  di: Reyhaneh Bayani, et al.
  Pubblicazione: (2025)
• Synchronous Bilateral Large Renal Cell Carcinoma Treated With Presurgical Pembrolizumab and Lenvatinib Enabling Unilateral Partial Nephrectomy and Dialysis Avoidance: A Case Report
  di: Hiroki Kawabata, et al.
  Pubblicazione: (2025)
• The Impact of Visceral Fat Accumulation on 24‐h Urine Chemistries and Stone‐Recurrence in Patients With Urolithiasis
  di: Ryusuke Deguchi, et al.
  Pubblicazione: (2025)
• Prognostic Impact of Initial Prostate Specific Antigen Half‐Life After Abiraterone Acetate in High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: Who May Need Triplet Therapy?
  di: Kotaro Suzuki, et al.
  Pubblicazione: (2026)